Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion type Assertion NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_head.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion wasGeneratedBy ECO_0000203 NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_provenance.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion wasDerivedFrom befree-20150227 NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_provenance.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion SIO_000772 22898604 NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_provenance.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion evidence source_evidence_literature NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_provenance.
- NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_assertion description "[Our studies demonstrate that inhibitors of autophagy or cathepsin B activity and/or molecular targeting of p62/SQSTM1, Atg7, or cathepsin B result in partial reversal of the suppressive effects of AS(2)O(3) on BCR-ABL expressing leukemic progenitors, including primitive leukemic precursors from chronic myelogenous leukemia (CML) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810151.RAFm6w1KwWceVJnWirD3MSC6lrZKMI0egK7pJnOdnPOqI130_provenance.